Silicone surface with drug nanodepots for medical devices

ACS Appl Mater Interfaces. 2014 Nov 26;6(22):20188-96. doi: 10.1021/am505566m. Epub 2014 Oct 28.

Abstract

An ideal surface of poly(dimethylsiloxane) (PDMS) medical devices requires sustained drug release to combat various tissue responses and infection. At present, a noncovalent surface coating with drug molecules using binders possesses a detachment problem, while covalently linking drug molecules to the surface provides no releasable drug. Here, a platform that allows the deposition of diverse drugs onto the PDMS surface in an adequate quantity with reliable attachment and a sustained-release character is demonstrated. First, a PDMS surface with carboxyl functionality (PDMS-COOH) is generated by subjecting a PDMS piece to an oxygen plasma treatment to obtain silanol moieties on its surface, then condensing the silanols with (3-aminopropyl)triethoxysilane molecules to generate amino groups, and finally reacting the amino groups with succinic anhydride. The drug-loaded carriers with hydroxyl groups on their surface can then be esterified to PDMS-COOH, resulting in a PDMS surface covalently grafted with drug-filled nanocarriers so that the drugs inside the securely grafted carriers can be released. Demonstrated here is the covalent linking of the surface of a PDMS endotracheal tube with budesonide-loaded ethylcellulose nanoparticles. A secure and high drug accumulation at the surface of the tubes (0.025 mg/cm2) can be achieved without changes in its bulk property such as hardness (Shore-A), and sustained release of budesonide with a high release flux during the first week followed by a reduced release flux over the subsequent 3 weeks can be obtained. In addition, the grafted tube possesses more hydrophilic surface and thus is more tissue-compatible. The grafted PDMS pieces show a reduced in vitro inflammation in cell culture and a lower level of in vivo tissue responses, including a reduced level of inflammation, compared to the unmodified PDMS pieces, when implanted in rats. Although demonstrated with budesonide and a PDMS endotracheal tube, this platform of grafting a PDMS surface with drug-loaded particles can be applied to other drugs and other devices.

Keywords: drug release; endotracheal tube; implantation; inflammation; silicone surface; surface functionalization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Budesonide / chemistry
  • Budesonide / pharmacology
  • Cell Line
  • Drug Carriers / chemistry*
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / toxicity
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Male
  • Mice
  • Nanoparticles / chemistry*
  • Nitric Oxide / metabolism
  • Propylamines
  • Rats
  • Rats, Wistar
  • Silanes / chemistry
  • Silicones / chemistry*

Substances

  • Anti-Inflammatory Agents
  • Drug Carriers
  • Lipopolysaccharides
  • Propylamines
  • Silanes
  • Silicones
  • Nitric Oxide
  • Budesonide
  • Interferon-gamma
  • amino-propyl-triethoxysilane